Compare · HUM vs PSNL
HUM vs PSNL
Side-by-side comparison of Humana Inc. (HUM) and Personalis Inc. (PSNL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and PSNL operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $48.02B, about 29.8x PSNL ($1.61B).
- Over the past year, HUM is up 81.5% and PSNL is up 149.4% - PSNL leads by 67.9 points.
- PSNL has been more active in the news (10 items in the past 4 weeks vs 6 for HUM).
- HUM has more recent analyst coverage (25 ratings vs 14 for PSNL).
- Company
- Humana Inc.
- Personalis Inc.
- Price
- $400.21+3.63%
- $15.39-1.25%
- Market cap
- $48.02B
- $1.61B
- 1M return
- +8.37%
- +58.99%
- 1Y return
- +81.54%
- +149.43%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2019
- News (4w)
- 6
- 10
- Recent ratings
- 25
- 14
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Personalis Inc.
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California.
Latest HUM
- Humana upgraded by Wells Fargo with a new price target
- SEC Form 4 filed by Director Hilzinger Kurt J
- The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants
- SEC Form 11-K filed by Humana Inc.
- SEC Form 11-K filed by Humana Inc.
- Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026
- Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State
- Humana Announces Agreement to Divest Minority Interest in Gentiva
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
Latest PSNL
- President and CMO Chen Richard exercised 100,000 shares at a strike of $2.44 and sold $1,515,000 worth of shares (100,000 units at $15.15) as part of a pre-agreed trading plan (SEC Form 4)
- Personalis Accelerates Global Expansion with UKCA Marking for NeXT Personal®, Expanding MRD Access and Biopharma Support in Great Britain
- Chief Executive Officer Hall Christopher M exercised 100,000 shares at a strike of $1.61 and sold $1,508,000 worth of shares (100,000 units at $15.08) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Personalis Inc.
- CFO AND COO Tachibana Aaron sold $69,748 worth of shares (4,982 units at $14.00) as part of a pre-agreed trading plan and exercised 4,982 shares at a strike of $5.32 (SEC Form 4)
- SEC Form 144 filed by Personalis Inc.
- CFO AND COO Tachibana Aaron exercised 51,251 shares at a strike of $7.48 and sold $675,488 worth of shares (51,251 units at $13.18) as part of a pre-agreed trading plan (SEC Form 4)
- Chief Executive Officer Hall Christopher M exercised 100,000 shares at a strike of $1.61 and sold $1,315,000 worth of shares (100,000 units at $13.15) as part of a pre-agreed trading plan (SEC Form 4)
- SEC Form 144 filed by Personalis Inc.
- SEC Form 144 filed by Personalis Inc.